dimethyl fumarate NDC 24979-128

NDC codes

FDA NDC Directory

Product NDC (as listed)24979-128Labeler and product segments. Claims need a package NDC.

Product NDC at billing width24979-0128Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
24979-128-02	24979012802	500 CAPSULE, DELAYED RELEASE in 1 BOTTLE, PLASTIC (24979-128-02)Marketed from Dec 1, 2020
24979-128-04	24979012804	60 CAPSULE, DELAYED RELEASE in 1 BOTTLE, PLASTIC (24979-128-04)Marketed from Dec 1, 2020

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): dimethyl fumarate
Generic name (nonproprietary): dimethyl fumarate
Active ingredients: Dimethyl fumarate — 240 mg/1
Dosage form: Capsule, Delayed release
Route: Oral
Labeler: Upsher-Smith Laboratories, LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 210382
Marketing start: Dec 1, 2020
Listing expires: Dec 31, 2027
Identifiers: Product ID 24979-128_8b1210a2-c1ad-44b7-8afe-a5c55bfb5be8SPL ID 8b1210a2-c1ad-44b7-8afe-a5c55bfb5be8SPL set ID 48f56f42-2247-41a9-a1e9-07c3af50e549RxCUI 1373483, 1373491UNII FO2303MNI2UPC 0324979127217, 0324979128047

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N424979012802 followed by a unit qualifier and the quantity

Package 24979-0128-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 19, 2026.

Indications (excerpt from the label)

Dimethyl fumarate delayed-release capsules are indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. Dimethyl fumarate delayed-release capsules are indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 210382

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 210382
Product	Strength	Form · route	Labeler	Product NDC
dimethyl fumarate	Dimethyl fumarate 120 mg/1	Capsule, Delayed releaseOral	Upsher-Smith Laboratories, LLC	24979-127
dimethyl fumarate	Dimethyl fumarate 120 mg/1	Capsule, Delayed releaseOral	Golden State Medical Supply, Inc.	51407-442
dimethyl fumarate	Dimethyl fumarate 240 mg/1	Capsule, Delayed releaseOral	Golden State Medical Supply, Inc.	51407-441